News
Stockhead on MSN3d
ASX biotechs join global race for cell therapy breakthroughsSeveral ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 ...
Experimental treatment could offer a safer, cheaper alternative to CAR-T-cell therapies for disorders such as lupus.
This article explores the relationship between the immune system and cancer and outlines therapeutic strategies that leverage ...
New report adds to growing evidence of iNKT cell therapy’s potential in solid tumors. NEW YORK, July 11, 2025 (GLOBE NEWSWIRE ...
The instinct to protect and secure a child’s future—especially when it comes to their health—is one of the deepest and most ...
NKGen Biotech, Inc. (OTC: NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization ...
Research led by Naval Medical University's Changzheng Hospital in China reports that an off-the-shelf cell therapy built from ...
ImmunityBio, Inc. (NASDAQ: IBRX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...
HealthDay on MSN1d
Presurgical Ablative Radiotherapy + Chemo Improves Pathologic Outcomes in Pancreatic CancerAdding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients ...
NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are ...
Blueberries, known for their deep blue to purple skin, are often called nature's superfood. When it comes to taste, they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback